SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 Induces Acute and Refractory Relapse of Systemic Capillary Leak Syndrome (Clarkson's Disease)

Published:2020-11 Issue:11 Volume:133 Page:e663-e664
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Pineton de Chambrun Marc^ORCID,Cohen-Aubart Fleur,Donker Dirk W.^ORCID,Cariou Pierre-Louis,Luyt Charles-Edouard,Combes Alain,Amoura Zahir

Publisher

Elsevier BV

Subject

General Medicine

Reference5 articles.

1. Cyclical edema and shock due to increased capillary permeability;Clarkson;Am J Med,1960

2. Intravenous immunoglobulins improve survival in monoclonal gammopathy-associated systemic capillary-leak syndrome;Pineton de Chambrun;Am J Med,2017

3. The systemic capillary leak syndrome: a case series of 28 patients from a European registry;Gousseff;Ann Intern Med,2011

4. The clinical picture of severe systemic capillary-leak syndrome episodes requiring ICU admission;Pineton de Chambrun;Crit Care Med,2017

5. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet,2020

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microfluidics as a Powerful Tool to Investigate Microvascular Dysfunction in Trauma Conditions: A Review of the State‐of‐the‐Art;Advanced Biology;2024-07-19

2. Fatal Systemic Capillary Leak Syndrome in a Patient with a COVID-19 Infection;Internal Medicine;2024-07-01

3. Intrinsic endothelial hyperresponsiveness to inflammatory mediators drives acute episodes in models of Clarkson disease;Journal of Clinical Investigation;2024-03-19

4. DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer models;Journal of Clinical Investigation;2024-03-07

5. Two cases of systemic capillary leak syndrome associated with COVID-19 in Japan;Journal of Infection and Chemotherapy;2023-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3